| Financial Year |
March 31 2023 |
| Monetary Funds |
1,519,601,953.76 |
| Held-for-trading Financial Assets |
1,761,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
792,660,413.45 |
| Advances to Suppliers |
46,125,003.44 |
| Other Receivables |
67,766,193.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
727,704,540.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,655,380.33 |
| Total Current Assets |
4,934,554,875.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
74,650,461.22 |
| Investment Properties |
52,035,569.04 |
| Fixed Assetes |
1,137,748,894.00 |
| Under-construction Projects |
95,065,721.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
109,219,109.34 |
| R&D expenses |
122,798,595.62 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
36,624,954.78 |
| Deferred Income Tax Assets |
44,240,997.68 |
| Other Non-Current Assets |
104,595,406.00 |
| Sub-Total of Non-Current Assets |
1,880,713,673.24 |
| Total Assets |
6,815,268,549.17 |
| Short-Term Loans |
45,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,401,402.04 |
| Accounts Payable |
250,101,994.39 |
| Accounts Received In Advance |
37,385,149.58 |
| Employee Compensation Payable |
-- |
| Taxes Payable |
162,604,341.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
342,645,820.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,542,998.37 |
| Other Current Liabilities |
1,839,064.25 |
| Sub-Total of Current Liabilities |
906,092,526.39 |
| Long-term Loans |
230,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
292,159.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
99,246,481.31 |
| Total Liabilities |
1,005,339,007.70 |
| Paid-In Capital(Or Share Stock) |
1,007,588,092.00 |
| Capital Surplus |
119,410,371.18 |
| Surplus Reserve |
503,794,046.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,205,782,227.06 |
| Minority Stockholder's Interest |
-39,748,496.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,849,678,037.83 |
| Owner's Equity（Stockholder's Equity） |
5,809,929,541.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,815,268,549.17 |
